Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3-(difluoromethyl)-1-methyl-n-(3',4',5'-trifluoro(1,1'-biphenyl)-2-yl)-1h-pyrazole-4-carboxamide
2. Xemium
1. 907204-31-3
2. Xemium
3. Fluxapyroxad [iso]
4. 3-(difluoromethyl)-1-methyl-n-[2-(3,4,5-trifluorophenyl)phenyl]pyrazole-4-carboxamide
5. 7u8p4nar2s
6. 3-(difluoromethyl)-1-methyl-n-(3',4',5'-trifluorobiphenyl-2-yl)pyrazole-4-carboxamide
7. 3-(difluoromethyl)-1-methyl-n-(3',4',5'-trifluoro(1,1'-biphenyl)-2-yl)-1h-pyrazole-4-carboxamide
8. 3-(difluoromethyl)-1-methyl-n-(3',4',5'-trifluoro-[1,1'-biphenyl]-2-yl)-1h-pyrazole-4-carboxamide
9. 3-(difluoromethyl)-1-methyl-n-(3',4',5'-trifluorobiphenyl-2-yl)-1h-pyrazole-4-carboxamide; Xemium
10. Unii-7u8p4nar2s
11. 3-(difluoromethyl)-1-methyl-n-(3',4',5'-trifluoro[1,1'-biphenyl]-2-yl)-1h-pyrazole-4-carboxamide
12. Schembl167627
13. Dtxsid6058215
14. Chebi:83113
15. Ex-a1676
16. Zinc35076028
17. Ac-36586
18. As-36599
19. Fluxapyroxad 100 Microg/ml In Acetonitrile
20. Hy-135549
21. Cs-0113442
22. Fluxapyroxad, Pestanal(r), Analytical Standard
23. Q15632875
24. 3-(difluoromethyl)-1-methyl-n-(3',4',5'-trifluorobiphenyl-2-yl)-1h-pyrazole-4-carboxamide
25. N-(2-(3,4,5-trifluorophenyl)phenyl)-3-difluoromethyl-1-methylpyrazole-4-carboxamide
26. N-(3',4',5'-trifluorobiphenyl-2-yl)-1-methyl-3-difluoromethyl-1h-pyrazole-4-carboxamide
27. N-(3',4',5'-trifluorobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1h-pyrazole-4-carboxamide
28. 1h-pyrazole-4-carboxamide, 3-(difluoromethyl)-1-methyl-n-(3',4',5'-trifluoro[1,1'-biphenyl]-2-yl)-
29. 3-(difluoromethyl)-1-methyl-n-(3 Inverted Exclamation Marka,4 Inverted Exclamation Marka,5 Inverted Exclamation Marka-trifluorobiphenyl-2-yl)pyrazole-4-carboxamide
| Molecular Weight | 381.3 g/mol |
|---|---|
| Molecular Formula | C18H12F5N3O |
| XLogP3 | 3.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 4 |
| Exact Mass | 381.09005283 g/mol |
| Monoisotopic Mass | 381.09005283 g/mol |
| Topological Polar Surface Area | 46.9 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 513 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Fluxapyroxad manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fluxapyroxad, including repackagers and relabelers. The FDA regulates Fluxapyroxad manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fluxapyroxad API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fluxapyroxad manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fluxapyroxad supplier is an individual or a company that provides Fluxapyroxad active pharmaceutical ingredient (API) or Fluxapyroxad finished formulations upon request. The Fluxapyroxad suppliers may include Fluxapyroxad API manufacturers, exporters, distributors and traders.
click here to find a list of Fluxapyroxad suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Fluxapyroxad Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fluxapyroxad GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fluxapyroxad GMP manufacturer or Fluxapyroxad GMP API supplier for your needs.
A Fluxapyroxad CoA (Certificate of Analysis) is a formal document that attests to Fluxapyroxad's compliance with Fluxapyroxad specifications and serves as a tool for batch-level quality control.
Fluxapyroxad CoA mostly includes findings from lab analyses of a specific batch. For each Fluxapyroxad CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fluxapyroxad may be tested according to a variety of international standards, such as European Pharmacopoeia (Fluxapyroxad EP), Fluxapyroxad JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fluxapyroxad USP).
LOOKING FOR A SUPPLIER?
